Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice

Journal of Ethnopharmacology

Volumn 146, Issue 3, 2013, Pages 773-793

  Liu, Hui ^a   Wang, Jinan ^a   Zhou, Wei ^a   Wang, Yonghua ^a   Yang, Ling ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Chinese herbal medicine; Drug discovery; Licorice; Network analysis; Systems pharmacology

Indexed keywords

ARTICLE; BLOOD BRAIN BARRIER; DRUG BIOAVAILABILITY; DRUG DEVELOPMENT; DRUG PENETRATION; DRUG SCREENING; ETHNOPHARMACOLOGY; GLYCYRRHIZA; SYSTEMS PHARMACOLOGY;

BIOLOGICAL AVAILABILITY; DRUG DISCOVERY; DRUGS, CHINESE HERBAL; ETHNOPHARMACOLOGY; GLYCYRRHIZA; MEDICINE, CHINESE TRADITIONAL; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NEURAL NETWORKS (COMPUTER); SOFTWARE; SYSTEMS ANALYSIS;

GLYCYRRHIZA;

EID: 84875507557     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.02.004     Document Type: Article

References (128)

1. A.P. Abernethy, D.C. Currow, P. Frith, B.S. Fazekas, A. McHugh, and C. Bui Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea British Medical Journal 327 2003 523 528
2. A.M. Aléssio, N.F. Höehr, L.H. Siqueira, M.C. Ozelo, A. de Pádua Mansur, and J.M. Annichino-Bizzacchi Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis Thrombosis Research 120 2007 639 645
3. M. Alavijeh, M. Chishty, M.Z. Qaiser, and A. Palmer Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery Neurotherapeutics 2 2005 554 571
4. A. Aly, L. Al-Alousi, and H. Salem Licorice: A possible anti-inflammatory and anti-ulcer drug AAPS PharmSciTech 6 2005 E74 E82
5. M.N. Asl, and H. Hosseinzadeh Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds Phytotherapy Research 22 2008 709 724
6. M. Aviram Flavonoids-rich nutrients with potent antioxidant activity prevent atherosclerosis development: the licorice example International Congress Series 1262 2004 320 327
7. U. Aytac, and N.H. Dang CD26/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy Current Drug Targets - Immune, Endocrine & Metabolic Disorders 4 2004 11 18
8. M. Bäck, D.F.J. Ketelhuth, and S. Agewall Matrix metalloproteinases in atherothrombosis Progress in Cardiovascular Diseases 52 2010 410 428
9. P.J. Barnes Pathophysiology of asthma British Journal of Clinical Pharmacology 42 1996 3 10
10. M.A. Birrell, N. Crispino, D.J. Hele, H.J. Patel, M.H. Yacoub, P.J. Barnes, and M.G. Belvisi Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD British Journal of Pharmacology 136 2002 620 628
11. A.D. Boran, and R. Iyengar Systems approaches to polypharmacology and drug discovery Current Opinion in Drug Discovery & Development 13 2010 297 309
12. V. Boswell-Smith, and D. Spina PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast International Journal of Chronic Obstructive Pulmonary Disease 2 2007 121 129
13. G. Cantelli-Forti, F. Maffei, P. Hrelia, F. Bugamelli, M. Bernardi, P. D'Intino, M. Maranesi, and M.A. Raggi Interaction of licorice on glycyrrhizin pharmacokinetics Environmental Health Perspectives 102 9 1994 65 68
14. F. Cheung Made in China Natural 2011 480
15. W.S. Cho, and C. Chae Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium Veterinary Pathology 41 2004 419 423
16. J.H. Choi, M.-C. Rho, S.W. Lee, O.E. Kwon, H.R. Park, J.Y. Kang, S.H. Lee, H.S. Lee, K.H. Bae, and Y.K. Kim Glabrol, an acyl-coenzyme A: cholesterol acyltransferase inhibitor from licorice roots Journal of Ethnopharmacology 110 2007 563 566
17. M.T. Chou, J. Wang, and D.J. Fujita Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells BMC Biochemistry 3 2002 32
18. F. Cipollone, G. Cicolini, and M. Bucci Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives Pharmacology & Therapeutics 118 2008 161 180
19. C. Csáki, T. Ferencz, R. Koós, D. Schuler, and J. Borsi Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology Orvosi Hetilap 134 1993 1363 1367
20. Y. Cui, M. Ao, W. Li, J. Hu, and L. Yu Anti-inflammatory activity of licochalcone A isolated from Glycyrrhiza inflata. Zeitschrift f? r Naturforschung. C Journal of Biosciences 63 2008
21. A. De Maio Heat shock proteins: facts, thoughts, and dreams Shock (Augusta, Ga.) 11 1999 1 12
22. R.C. Dunphy, and G.N. Verne Drug treatment options for irritable bowel syndrome: managing for success Drugs & Aging 18 2001 201 211
23. Eddy, N.B., Friebel, H., Hahn, K.J., Halbach, H., 1969. Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine-mechanism, methodology and evaluation.
24. X.-K. Fang, J. Gao, and D.-N. Zhu Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity Life Sciences 82 2008 615 622
25. C.M. Ferrario, and W.B. Strawn Role of the Renin-Angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease The American Journal of Cardiology 98 2006 121 128
26. C. Fiore, M. Eisenhut, E. Ragazzi, G. Zanchin, and D. Armanini A history of the therapeutic use of liquorice in Europe Journal of Ethnopharmacology 99 2005 317 324
27. Y. Fu, T.-c. Hsieh, J. Guo, J. Kunicki, M.Y.W.T. Lee, Z. Darzynkiewicz, and J.M. Wu Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells Biochemical and Biophysical Research Communications 322 2004 263 270
28. B. Fuhrman, N. Volkova, M. Kaplan, D. Presser, J. Attias, T. Hayek, and M. Aviram Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure Nutrition 18 2002 268 273
29. Y. Fujisawa, M. Sakamoto, M. Matsushita, T. Fujita, and K. Nishioka Glycyrrhizin inhibits the lytic pathway of complement - possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis Microbiology and Immunology 44 2000 799
30. I. Furuhashi, S. Iwata, T. Sato, H. Inoue, and S. Shibata Inhibition by licochalcone A, a novel flavonoid isolated from liquorice root, of IL-1β-induced PGE2 production in human skin fibroblasts Journal of Pharmacy and Pharmacology 57 2005 1661 1666
31. I. Gavras, A.J. Manolis, and H. Gavras The α2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies Journal of Hypertension 19 2001 2115 2124
32. R. Gaware, R. Khunt, L. Czollner, C. Stanetty, T.D. Cunha, D.V. Kratschmar, A. Odermatt, P. Kosma, U. Jordis, and D. Claßen-Houben Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors Bioorganic & Medicinal Chemistry 19 2011 1866 1880
33. D. Gingras, A. Renaud, N. Mousseau, E. Beaulieu, Z. Kachra, and R. Beliveau Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound Anticancer Research 21 2001 145 155
34. J. Goñi, F.J. Esteban, N. de Mendizábal, J. Sepulcre, S. Ardanza-Trevijano, I. Agirrezabal, and P. Villoslada A computational analysis of protein-protein interaction networks in neurodegenerative diseases BMC System Biology 2 2008 52
35. M. Goiny, and K. Uvnäs-Moberg Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine Naunyn-Schmiedeberg's Archives of Pharmacology 336 1987 16 19
36. J. Gu, H. Zhang, L. Chen, S. Xu, G. Yuan, and X. Xu Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus Computational Biology and Chemistry 35 2011 293 297
37. Y. Gu, G.J. Wang, J.G. Sun, Y.W. Jia, W. Wang, M.J. Xu, T. Lv, Y.T. Zheng, and Y. Sai Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs Food and Chemical Toxicology 47 2009 2257 2268
38. A. Gursoy, O. Keskin, and R. Nussinov Topological properties of protein interaction networks from a structural perspective Biochemical Society Transactions 36 2008 1398 1403
39. T. Hatano, T. Yasuhara, K. Miyamoto, and T. Okuda Anti-human immunodeficiency virus phenolics from licorice Chemical & Pharmaceutical Bulletin 36 1988 2286 2288
40. R. Haworth, K. Oakley, N. McCormack, and A. Pilling Differential expression of COX-1 and COX-2 in the gastrointestinal tract of the rat Toxicologic Pathology 33 2005 239 245
41. J.Q. He, and M. van Lookeren Campagne Macrophage metalloelastase: stretching therapeutic opportunities Journal of Molecular Cell Biology 2009
42. G. Hongxia, S. Shihe, and W. Guoqing Research progress of glycyrrhiza uralensis fisch Journal of Jinggangshan Medical College 11 2004 8 11
43. A.L. Hopkins Network pharmacology Nature Biotechnology 25 2007 1110 1111
44. A.L. Hopkins Network pharmacology: the next paradigm in drug discovery Nature Chemical Biology 4 2008 682 690
45. H. Inoue, H. Saito, Y. Koshihara, and S.-I. Murota Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase Chemical & Pharmaceutical Bulletin 34 1986 897 901
46. A.L. Jennings, A.N. Davies, J.P.T. Higgins, J.S.R. Gibbs, and K.E. Broadley A systematic review of the use of opioids in the management of dyspnoea Thorax 57 2002 939 944
47. H. Jeong, S.P. Mason, A.L. Barabasi, and Z.N. Oltvai Lethality and centrality in protein networks Nature 411 2001 41 42
48. J. Kamei, A. Saitoh, T. Asano, R. Nakamura, H. Ichiki, A. Iiduka, and M. Kubo Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo-to (Mai-men-dong-tang) European Journal of Pharmacology 507 2005 163 168
49. J. Kamei, H. Tanihara, and Y. Kasuya Modulation of μ-mediated antitussive activity in rats by a δ agonist European Journal of Pharmacology 203 1991 153 156
50. A. Kanehiro, T. Ikemura, M. MÄKelÄ, M. Lahn, A. Joetham, A. Dakhama, and E. Gelfand Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge American Journal of Respiratory and Critical Care Medicine 163 2001 173 184
51. J.A. Karlsson, A.S. Lanner, and C.G. Persson Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs The Journal of Pharmacology and Experimental Therapeutics 252 1990 863 868
52. Z.A. Kassir Endoscopic controlled trial of four drug regimens in the treatment of chronic duodenal ulceration Irish Medical Journal 78 1985 153 156
53. D.B. Kitchen, H. Decornez, J.R. Furr, and J. Bajorath Docking and scoring in virtual screening for drug discovery: methods and applications Nature Reviews: Drug Discovery 3 2004 935 949
54. R.K. Kumar, C. Herbert, P.S. Thomas, L. Wollin, R. Beume, M. Yang, D.C. Webb, and P.S. Foster Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma Journal of Pharmacology and Experimental Therapeutics 307 2003 349 355
55. H. Kuss, N. Hoefgen, S. Johanssen, T. Kronbach, and C. Rundfeldt In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4- fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration Journal of Pharmacology and Experimental Therapeutics 307 2003 373 385
56. K. Lee, C.W. Park, W.-H. Jung, H.D. Park, S.H. Lee, K.H. Chung, S.K. Park, O.H. Kwon, M. Kang, D.-H. Park, S.K. Lee, E.E. Kim, S.K. Yoon, and A. Kim Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d- diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide Journal of Medicinal Chemistry 46 2003 3612 3622
57. L. Li, Y. Li, Y. Wang, and S. Zhang Prediction of BBB permeation based on molecular indices Chinese Journal of Medicinal Chemistry 17 2007 221 228
58. S. Li, B. Zhang, and N. Zhang Network target for screening synergistic drug combinations with application to traditional Chinese medicine BMC Systems Biology 5 2011 S10
59. Li, X., Xu, X., Wang, J., Yu, H., Wang, X., Yang, H., Xu, H., Tang, S., Li, Y., Ling Yang, L.H., Yonghua Wang, Shengli Yang, 2012. A system-level investigation into the mechanisms of Chinese Traditional Medicine compound danshen formula for cardiovascular disease treatment. Plos One 7(9), 2012, e43918. 10.1371/journal.pone.0043918.
60. Lim, W.Y., Chia, Y.Y., Liong, S.Y., Ton, S.H., Kadir, K.A., Husain, S.N., Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally administered glycyrrhizic acid-treated rats. Lipids in Health and Disease 8, 2009, 31.
61. B. Liu, J. Yang, Q. Wen, and Y. Li Isoliquiritigenin, a flavonoid from licorice, relaxes guinea-pig tracheal smooth muscle in vitro and in vivo: role of cGMP/PKG pathway European Journal of Pharmacology 587 2008 257 266
62. R. Liu, H. Sun, and S.-S. So Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration Journal of Chemical Information and Computer Sciences 41 2001 1623 1632
63. T. Maeda, K. Shinozuka, K. Baba, M. Hayashi, and E. Hayashi Effect of shakuyaku-kanzoh-toh, a prescription composed of shakuyaku (Paeoniae Radix) and kanzoh (Glycyrrhizae Radix) on guinea pig ileum Journal of Pharmacobio-Dynamics 6 1983 153
64. I. Mauricio, B. Francischetti, R.Q. Monteiro, and J.A. Guimarães Identification of glycyrrhizin as a thrombin inhibitor Biochemical and Biophysical Research Communications 235 1997 259 263
65. W. Mendes-Silva, M. Assafim, B. Ruta, R.Q. Monteiro, J.A. Guimarães, and R.B. Zingali Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor Thrombosis Research 112 2003 93 98
66. L. Mollica, F. De Marchis, A. Spitaleri, C. Dallacosta, D. Pennacchini, M. Zamai, A. Agresti, L. Trisciuoglio, G. Musco, and M.E. Bianchi Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities Chemistry & Biology 14 2007 431 441
67. G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, and A.J. Olson AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility Journal of Computational Chemistry 30 2009 2785 2791
68. S. Mukhopadhyay, J. Sypek, R. Tavendale, U. Gartner, J. Winter, W. Li, K. Page, M. Fleming, J. Brady, M. O'Toole, D.F. Macgregor, S. Goldman, S. Tam, W. Abraham, C. Williams, D.K. Miller, and C.N.A. Palmer Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults Journal of Allergy and Clinical Immunology 126 2010 70-76.e16
69. Y. Nagahata, Y. Azumi, N. Kawakita, T. Wada, and Y. Saitoh Inhibitory effect of dopamine on gastric motility in rats Scandinavian Journal of Gastroenterology 30 1995 880 885
70. H. Nagai, J.X. He, T. Tani, and T. Akao Antispasmodic activity of licochalcone A, a species-specific ingredient of Glycyrrhiza inflata roots Journal of Pharmacy and Pharmacology 59 2007 1421 1426
71. y mice Biological and Pharmaceutical Bulletin 27 2004 1775 1778
72. R. Nakamura, Y. Kase, K. Hashimoto, I. Sakakibara, S. Amagaya, and M. Aburada Elucidation of anti-gastric ulcer constituents of Glycyrrhizae Radix Natural Medicines 57 2003 172 177
73. H. Nishino, K. Kitagawa, and A. Iwashima Antitumor-promoting activity of glycyrrhetic acid in mouse skin tumor formation induced by 7,12-dimethylbenz[a] anthracene plus teleocidin Carcinogenesis 5 1984 1529 1530
74. K. Numazaki, N. Nagata, T. Sato, and S. Chiba Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U-937 and MRC-5 cells by human cytomegalovirus Journal of Leukocyte Biology 55 1994 24 28
75. Park, H.Y., Park, S.H., Yoon, H.K., Han, M.J., Kim, D.H., 2004. Anti-allergic activity of 18beta-glycyrrhetinic acid-3-O-beta-d-glucuronide, Archives of Pharmacal Research 27(1), 2004, 57-60.
76. R.A. Pauwels, and K.F. Rabe Burden and clinical features of chronic obstructive pulmonary disease (COPD) The Lancet 364 2004 613 620
77. D. Pawlak, K. Pawlak, E. Chabielska, J. Małyszko, A. Takada, M. Myśliwiec, and W. Buczko A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats Thrombosis Research 90 1998 259 270
78. B.J. Pleuvry Physiology and pharmacology of nausea and vomiting Anaesthesia & Intensive Care Medicine 7 2006 473 477
79. B. Ploeger, T. Mensinga, A. Sips, W. Seinen, J. Meulenbelt, and J. DeJongh The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling Drug Metabolism Reviews 33 2001 125 147
80. PRC, S.P.C.o.t., 2005. Pharmacopoeia of People's Republic of China. Chemical Industry Press, Beijing.
81. Z.K. Qiu, and B.H. Feng The role of main active ingredient of licorice in anti-tumor and neuroprotection Chinese Journal of Neuro-Oncology 7 2009 70 76
82. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, and J. Zielinski Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 176 2007 532 555
83. L. Račková, V. Jančinová, M. Petríková, K. Drábiková, R. Nosáľ, M. Štefek, D. Košťálová, N. Pró nayová, and M. Kováčová Mechanism of anti-inflammatory action of liquorice extract and glycyrrhizin Natural Product Research 21 2007 1234 1241
84. S. Rahman, and S. Sultana Glycyrrhizin exhibits potential chemopreventive activity on 12-O-tetradecanoyl phorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in swiss albino mice Journal of Enzyme Inhibition and Medicinal Chemistry 22 2007 363 369
85. A. Ram, U. Mabalirajan, M. Das, I. Bhattacharya, A.K. Dinda, S.V. Gangal, and B. Ghosh Glycyrrhizin alleviates experimental allergic asthma in mice International Immunopharmacology 6 2006 1468 1477
86. F.E. Revers Licorice juice in therapy of ventricular and duodenal ulcers [in Dutch] Ned Tijdschr Geneeskd 92 1948 2968 2972
87. K. Sangkuhl, A.R. Shuldiner, T.E. Klein, and R.B. Altman Platelet aggregation pathway Pharmacogenetics and Genomics 21 2011 516 521
88. H. Sato, W. Goto, J.-i. Yamamura, M. Kurokawa, S. Kageyama, T. Takahara, A. Watanabe, and K. Shiraki Therapeutic basis of glycyrrhizin on chronic hepatitis B Antiviral Research 30 1996 171 177
89. Y. Sato, T. Akao, J.X. He, H. Nojima, Y. Kuraishi, T. Morota, T. Asano, and T. Tani Glycycoumarin from Glycyrrhizae Radix acts as a potent antispasmodic through inhibition of phosphodiesterase 3 Journal of Ethnopharmacology 105 2006 409 414
90. Y. Sato, J.-X. He, H. Nagai, T. Tani, and T. Akao Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza Ularensis roots, acts in the lower part of intestine Biological and Pharmaceutical Bulletin 30 2007 145 149
91. P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Research 13 2003 2498 2504
92. S.D. Shapiro Animal models for COPD CHEST Journal 117 2000 223S 227S
93. K.A. Smoak, and J.A. Cidlowski Mechanisms of glucocorticoid receptor signaling during inflammation Mechanisms of Ageing and Development 125 2004 697 706
94. D. Somjen, E. Knoll, J. Vaya, N. Stern, and S. Tamir Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo The Journal of Steroid Biochemistry and Molecular Biology 91 2004 147 155
95. F. Spencer, and R. Becker Novel inhibitors of factor X for use in cardiovascular diseases Current Cardiology Reports 2 2000 395 404
96. J. Spencer Flavonoids: modulators of brain function British Journal of Nutrition 99 2008 60 77
97. H.-X. Sun, and H.-J. Pan Immunological adjuvant effect of Glycyrrhiza uralensis saponins on the immune responses to ovalbumin in mice Vaccine 24 2006 1914 1920
98. Y. Uchiyama, S. Okuno, H. Nakase, T. Sakaki, T. Inoue, and M. Koyama Experimental study of pharmacological hypothermia: enhanced neuroprotective effect of a novel 5-HT1A agonist SUN N4057 by the pharmacological hypothermia Brain Nerve 53 2001 853 858
99. A.F. Valledor, and M. Ricote Nuclear receptor signaling in macrophages Biochemical Pharmacology 67 2004 201 212
100. H Van Aken, B.C. Darius, H Diehm, C Encke, A Gulba, DC Haas, S Hacke, W Puhl, W Quante, M Riess, H Scharf, R Schellong, S Schrör, T Schulte, and KL Tebbe U. Anticoagulation: the present and future Clinical and Applied Thrombosis/Hemostasis 7 2001 195 204
101. J. Van Marle, P.N. Aarsen, A. Lind, and J. Van Weeren-Kramer Deglycyrrhizinised liquorice (DGL) and the renewal of rat stomach epithelium European Journal of Pharmacology 72 1981 219 225
102. J. Vaya, P.A. Belinky, and M. Aviram Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation Free Radical Biology and Medicine 23 1997 302 313
103. S. Verma, and P.E. Szmitko The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis Canadian Journal of Cardiology 22 2006 12B 17B
104. N.P. Visavadiya, and A.V.R.L. Narasimhacharya Hypocholesterolaemic and antioxidant effects of Glycyrrhiza glabra (Linn) in rats Molecular Nutrition & Food Research 50 2006 1080 1086
105. N.P. Visavadiya, B. Soni, and N. Dalwadi Evaluation of antioxidant and anti-atherogenic properties of Glycyrrhiza glabra root using in vitro models International Journal of Food Sciences and Nutrition 60 2009 135 149
106. P. Wang, P.O. Anderson, S. Chen, K.M. Paulsson, H.-O. Sjögren, and S. Li Inhibition of the transcription factors AP-1 and NF-κB in CD4 T cells by peroxisome proliferator-activated receptor γ ligands International Immunopharmacology 1 2001 803 812
107. Y.-C. Wang, and Y.-S. Yang Simultaneous quantification of flavonoids and triterpenoids in licorice using HPLC Journal of Chromatography B 850 2007 392 399
108. Z. Wang, Y. Kurosaki, T. Nakayama, and T. Kimura Mechanism of gastrointestinal absorption of glycyrrhizin in rats Biological & Pharmaceutical bulletin 17 1994 1399 1403
109. E.M. Williamson Synergy and other interactions in phytomedicines Phytomedicine 8 2001 401 409
110. B.H. Wu, C.L. Hu, W.B. Wu, C.G. Long, Q.R. Li, and X.D. Zhang Protective effect of flavononids from glycyrrhiza (FG) on focal cerebral ischemia reperfusion Henan Journal of Practical Nervons Diseases 2003 6
111. Z. Xiang, L. Ho, J. Valdellon, D. Borchelt, K. Kelley, L. Spielman, P.S. Aisen, and G.M. Pasinetti Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology Neurobiology of Aging 23 2002 327 334
112. L. Xie, L. Xie, S.L. Kinnings, and P.E. Bourne Novel computational approaches to polypharmacology as a means to define responses to individual drugs Annual Review of Pharmacology and Toxicology 52 2012 361 379
113. S.R. Xie, C.Y. Huang, S.Y. Huang, C.B. Sun, Z.G. Yu, and J. Zhao Antiarrhythmic effect of glycyrrhetinic acid Herald of Medicine 23 2004 140 142
114. Y.C. Xie, X.W. Dong, X.M. Wu, X.F. Yan, and Q.M. Xie Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice International Immunopharmacology 9 2009 194 200
115. K. Xu, B.H. Wu, C.P. Jiang, and C.L. Hu Effect of flavononids from Glycyrrhiza(FG) on nitric oxide and neuron specific enolase after focal cerebral ischemia reperfusion Journal of North Sichuan Medical College 21 2006 220 222
116. Xu Q., Qu F., Pelkonen O., 2012a. Network Pharmacology and Traditional Chinese Medicine. In: Sakagami H (Ed.) Alternative Medicine, Intech, 2012 (ISBN:978-953-51-0903-7), pp. 277-297.
117. X. Xu, W. Zhang, C. Huang, Y. Li, Y. Hua, Y. Wang, J. Duan, and L. Yang A novel chemometric method for prediction of human oral bioavailability International Journal of Molecular Sciences 13 2012 6964 6982
118. Z.G. Xu One step at a time Natural 2011 480
119. Y. Yamanishi, M. Kotera, M. Kanehisa, and S. Goto Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework Bioinformatics 26 2010 i246 i254
120. Y.M. Yang, J.M. Qin, J.H. Xu, K. Ying, and C.Z. Zhang Effect of total flavones of radix et folium Glycyrrhizae on thrombogenesis and coagulation time in rats Journal of Baotou Medical College 19 2003 90 91
121. M.A. Yildirim, K.-I. Goh, M.E. Cusick, A.-L. Barabasi, and M. Vidal Drug-target network Nature Biotechnology 25 2007 1119 1126
122. H. Yu, J. Chen, X. Xu, Y. Li, H. Zhao, Y. Fang, X. Li, W. Zhou, W. Wang, and Y. Wang A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data PLOS ONE 7 2012 e37608
123. H. Yuan, W.S. Ji, K.X. Wu, J.X. Jiao, L.H. Sun, and Y.T. Feng Anti-inflammatory effect of diammonium glycyrrhizinate in a rat model of ulcerative colitis World Journal of Gastroenterology 12 2006 4578 4581
124. C. Zhan, and J. Yang Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats Pharmacological Research 53 2006 303 309
125. C. Zhang, X.L. Dai, C.J. Lin, Y.X. Sun, and Z.F. Jiang Research on the application of licorice on cardio-cerebrovascular disease Journal of Beijing Union University(Natural Sciences) 24 2010 69 72
126. M.F. Zhang, and Y.Q. Shen Advances in studies on Glycyrrhizae Radix et Rhizoma and its active components in anti-inflammation and mechanism Drugs & Clinic 26 2011 261 268
127. S.F. Zhou, Z.W. Zhou, C.G. Li, X. Chen, X. Yu, C.C. Xue, and A. Herington Identification of drugs that interact with herbs in drug development Drug Discovery Today 12 2007 664 673
128. M.Z. Zhu, L. Gao, X. Li, Z.C. Liu, C. Xu, Y.Q. Yan, E. Walker, W. Jiang, B. Su, X.J. Chen, and H. Lin The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network Journal of Drug Targeting 17 2009 524 532